Gene testing for advanced hard-to-treat cancers
Part of Cancer, Digestive system, Skin clinical trials.
This study tests if early genetic testing of your tumor can help find targeted treatments for advanced cancers that are hard to treat, such as pancreatic, liver, or triple-negative breast cancer. It aims to match you with a therapy based on your tumor's genetic profile.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your cancer is advanced and cannot be surgically removed or has spread to other parts of the body.
- You have pancreatic, liver, or triple-negative breast cancer that has a poor outlook.
- You are newly diagnosed or just starting your first treatment for advanced disease.
- Your overall health is good (able to care for yourself and do daily activities).
- You have a tumor tissue sample (from a biopsy or surgery) available for genetic testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the genes in your cancer to find a treatment that might work better for you. It tests your tumor sample to match you with a drug that targets your cancer's specific weaknesses.
This study looks at whether using a detailed genetic test of your tumor can help pick the best first or second treatment for advanced lung, colon, breast, or bladder cancer. The goal is to see if this personalized approach helps people live longer.
This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.
This trial investigates genetic testing (mutational profiling) in people with various advanced cancers. It aims to understand how these tests can guide more personalized treatment decisions.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This study uses your tumor’s genetic test results to help match you to the most suitable treatment when standard options have failed or don’t exist. It may help by targeting therapies based on specific gene changes found in your cancer.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.